IL22 and colitis: In our experiment, the results of the multiplex immunoassay showed a partial change in ILC3-associated cytokines such as IL-22 and GM-CSF, but the more noticeable difference was in ILC2-derived cytokines, including IL-10, which could modulate DSS-induced colitis through a macrophage–ROS–NO axis [74].